Published in Pancreas on August 01, 2013
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology (2016) 1.09
Secretin stimulation test for gastrin release in Zollinger-Ellison syndrome: to do or not to do? Pancreas (2013) 0.76
Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol (2017) 0.75
Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome. Dig Dis Sci (2017) 0.75
Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells. Gastroenterology (2017) 0.75
Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg (1955) 10.98
Extraction of a gastrin-like substance from a pancreatic tumour in a case of Zollinger-Ellison syndrome. Lancet (1960) 3.18
Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety. N Engl J Med (1968) 2.54
Effect of secretin on serum gastrin as measured by immunoassay. Gastroenterology (1971) 2.40
Zollinger-Ellison syndrome. Gastroenterology (1973) 1.79
Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med (1989) 1.78
Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology (1972) 1.50
Gastrin (second of two parts). N Engl J Med (1975) 1.49
Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med (1983) 1.42
Endocrine cells in the antro-pyloric mucosa of the stomach. Z Zellforsch Mikrosk Anat (1967) 1.40
Secretin injection test in the diagnosis of gastrinoma. Gastroenterology (1980) 1.33
Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment Pharmacol Ther (2001) 1.01
A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans. Pancreas (2012) 0.96
Gastrin release from antral G cells stimulated with secretin. Am J Gastroenterol (1992) 0.90
Inhibition of gastrin release by secretin is mediated by somatostatin in cultured rat antral mucosa. J Clin Invest (1983) 0.89
Serum pancreastatin: the long sought universal, sensitive, specific tumor marker for neuroendocrine tumors? Pancreas (2012) 0.89
Gastrin release from gastrinoma cells stimulated with secretin. Dig Dis Sci (1982) 0.88
False-positive secretin stimulation test for gastrinoma associated with the use of proton pump inhibitor therapy. Clin Gastroenterol Hepatol (2009) 0.87
Positive intravenous secretin test in patients with achlorhydria-related hypergastrinemia. Gastroenterology (1987) 0.85
Diagnosis of the Zollinger–Ellison syndrome. Clin Gastroenterol Hepatol (2011) 0.85
Effect of fundusectomy on serum and antral gastrin levels in rats. Gastroenterology (1977) 0.85
The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment. Clin Gastroenterol Hepatol (2011) 0.84
Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results. J Clin Endocrinol Metab (2007) 0.84
A retrospective study of the usefulness of acid secretory testing. Aliment Pharmacol Ther (2000) 0.80
Calcium and secretin-stimulated gastrin release in the Zollinger-Ellison syndrome. Ann Intern Med (1974) 0.79
False-positive gastrin rises after secretin injection. J Lab Clin Med (1985) 0.79
A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome. Aliment Pharmacol Ther (2001) 0.79
Diagnostic efficacy of the secretin stimulation test for the Zollinger-Ellison syndrome: an intra-individual comparison using different dosages in patients and controls. Pancreatology (2010) 0.79
False-positive secretin test. Ann Intern Med (1978) 0.78
Is the gastrin response to secretin provocation a function of antral G-cell mass? Results in the hypergastrinemia of acid hyposecretion. J Clin Gastroenterol (1989) 0.78
Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA (2006) 9.53
Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol (2003) 2.20
Achalasia: a disease of varied and subtle symptoms that do not correlate with radiographic findings. Am J Gastroenterol (2002) 2.16
Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease. Eur J Gastroenterol Hepatol (2005) 2.15
Importance of surveillance for multiple endocrine neoplasia-1 and surgery in patients with sporadic Zollinger-Ellison syndrome. Clin Gastroenterol Hepatol (2012) 2.00
Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med (2008) 1.99
Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion (2011) 1.80
Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med (2004) 1.72
A randomized, controlled, double-blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoscopy. Anesth Analg (2008) 1.71
Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas (2013) 1.65
Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis (2004) 1.63
A prospective, randomized, comparative trial evaluating respiratory depression during patient-controlled versus anesthesiologist-administered propofol-remifentanil sedation for elective colonoscopy. Gastrointest Endosc (2010) 1.57
Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst (2014) 1.50
Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci (2007) 1.50
Ineffective motility is not a marker for gastroesophageal reflux disease. Am J Gastroenterol (2003) 1.50
Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry (2015) 1.43
A case of Cronkhite-Canada syndrome with taste disturbance as a leading complaint. Digestion (2005) 1.41
Safety of proton pump inhibitor exposure. Gastroenterology (2010) 1.37
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology (2012) 1.16
Successful aspiration and ethanol sclerosis of a large, symptomatic, simple liver cyst: case presentation and review of the literature. World J Gastroenterol (2006) 1.12
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med (2010) 1.11
No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.05
Do diabetes drugs modify the risk of pancreatic cancer? Gastroenterology (2009) 1.04
Management of patients with nonvariceal upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2011) 1.03
Metformin and survival in pancreatic cancer: a retrospective cohort study. Pancreas (2013) 1.03
Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care (2005) 1.00
Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf (2012) 0.99
Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol (2005) 0.98
Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf (2006) 0.97
Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Cancer (2012) 0.96
Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature. World J Gastroenterol (2005) 0.93
Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology (2009) 0.93
Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology (2005) 0.91
Radiographic appearance of a catheter-free wireless esophageal pH probe. AJR Am J Roentgenol (2005) 0.91
Insulin therapy and colorectal adenomas in patients with diabetes mellitus. Cancer Epidemiol Biomarkers Prev (2012) 0.88
Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiol Drug Saf (2008) 0.88
Hepatitis C knowledge among primary care residents: is our teaching adequate for the times? Am J Gastroenterol (2004) 0.88
Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiol Drug Saf (2008) 0.87
Clostridium difficile colitis: wash your hands before stopping the proton pump inhibitor. Am J Gastroenterol (2008) 0.85
Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. J Clin Epidemiol (2007) 0.85
Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women. Menopause (2012) 0.84
Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol (2007) 0.84
Uses of proton pump inhibitors and serum potassium levels. Pharmacoepidemiol Drug Saf (2009) 0.84
Long-term outcome of laparoscopic Nissen and laparoscopic Toupet fundoplication for gastroesophageal reflux disease: a prospective, randomized trial. Surg Endosc (2009) 0.82
Digoxin use and the risk for colorectal cancer. Pharmacoepidemiol Drug Saf (2014) 0.82
Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf (2015) 0.81
Risk factors for aggressive nonfunctional pancreatic neuroendocrine tumors and the role of endoscopic ultrasound guided fine-needle aspiration. Endosc Ultrasound (2016) 0.81
Influence of age and gender on gastric acid secretion as estimated by integrated acidity in patients referred for 24-hour ambulatory pH monitoring. Am J Gastroenterol (2003) 0.80
Effects of overexpression of antioxidants on the release of cytochrome c and apoptosis-inducing factor in the model of ischemia. Neurosci Lett (2009) 0.79
The efficacy of endoscopic therapy in bleeding peptic ulcer patients. S Afr Med J (2012) 0.79
Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol (2005) 0.79
Barrett's esophagus in 2008: an update. Keio J Med (2008) 0.79
Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology (2005) 0.79
Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study. Eur J Gastroenterol Hepatol (2015) 0.79
PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target. Cancer Biol Ther (2015) 0.79
Changes of the HSD17B10 gene expression levels in ulcerative colitis. Inflamm Bowel Dis (2013) 0.78
Findings on serial surveillance colonoscopy in patients with low-risk polyps on initial colonoscopy. J Clin Gastroenterol (2010) 0.77
Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms. Scand J Gastroenterol (2006) 0.77
Ghrelin does not predict adaptive hyperphagia in patients with short bowel syndrome. JPEN J Parenter Enteral Nutr (2009) 0.77
Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. Dig Dis Sci (2006) 0.77
Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol (2014) 0.76
Oxyntic mucosa pseudopolyps: a presentation of atrophic autoimmune gastritis. Am J Surg Pathol (2003) 0.76
Gastroesophageal reflux and sleep events in obstructive sleep apnea. Eur J Gastroenterol Hepatol (2013) 0.76
Weight Gain in Zollinger-Ellison Syndrome After Acid Suppression. Pancreas (2016) 0.75
Balancing the risks and benefits of proton pump inhibitors. Ann Fam Med (2011) 0.75
Therapy for gastroesophageal reflux disease: more is not necessarily better. Am J Gastroenterol (2003) 0.75
Diagnosis of pernicious anemia and the risk of pancreatic cancer. Pancreas (2014) 0.75
Segmental increases in force application during colonoscope insertion: quantitative analysis using force monitoring technology. Gastrointest Endosc (2012) 0.75
Response to Dr Waldum's letter regarding 'Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease'. Eur J Gastroenterol Hepatol (2005) 0.75
Sudden Tracheal Collapse during EGD and Subsequent Anesthetic Management with Dexmedetomidine-Ketamine in a Patient with Achalasia and Tracheomalacia. Case Rep Anesthesiol (2011) 0.75
HNPCC-associated pheochromocytoma: expanding the tumor spectrum. Pancreas (2015) 0.75
Reply: To PMID 22902777. Clin Gastroenterol Hepatol (2013) 0.75
Factors Predicting Testing and Treatment of Iron Deficiency in a Nationwide Cohort of Anemic UC Patients. Inflamm Bowel Dis (2016) 0.75
Image of the month. Mantle cell lymphoma. Gastroenterology (2002) 0.75
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis. Pancreas (2017) 0.75
Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors. Clin Nucl Med (2015) 0.75
A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis. Inflamm Bowel Dis (2017) 0.75
Competitive speed eating: truth and consequences. AJR Am J Roentgenol (2007) 0.75
Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancy. J Clin Gastroenterol (2007) 0.75
Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD: A Double-Blind Randomized Trial. J Clin Gastroenterol (2017) 0.75
Energy absorption is reduced with oleic acid supplements in human short bowel syndrome. JPEN J Parenter Enteral Nutr (2008) 0.75
Gastrointestinal cancer prevention in the United States: the road ahead. Cancer Epidemiol Biomarkers Prev (2003) 0.75